3.8 Article

Baseline C-reactive protein levels and prognosis in patients with infective endocarditis: A prospective cohort study

Journal

INDIAN HEART JOURNAL
Volume 70, Issue -, Pages S43-S49

Publisher

ELSEVIER
DOI: 10.1016/j.ihj.2018.05.001

Keywords

Infective endocarditis; C-reactive protein; Prognostication; Valvular heart disease; Biomarker

Ask authors/readers for more resources

Background: Early diagnosis and risk-stratification among infective endocarditis (LE) patients are limited by poor microbiological yield and inadequate characterization of vegetations. A simple tool that can predict adverse outcomes in the early phase of management is required. Aim: To study the prognostic value of C-reactive protein (CRP) levels at admission and its role in predicting various clinical outcomes. Methods: In a prospective study of consecutive IE patients diagnosed by modified Duke's criteria, we measured the peak levels of CRP and erythrocyte sedimentation rate (ESR) in the first 3 days of admission and correlated it with in-hospital mortality, six-month mortality, embolic phenomena and the need for urgent surgery. Predefined laboratory-microbiological sampling protocols and antibiotic-initiation protocols were followed. Receiver-operating-characteristics curves were generated to identify a reliable cut-off for CRP in predicting various outcomes. Results: Out of 101 patients who were treated, 85 patients had 'definite' IE. Blood cultures were positive in 55% (n = 39); and Staphylococcus species was the most common organism. Major complications occurred in 74.1% (n = 63) and in-hospital mortality was 32.9% (n = 28). Mean ESR and CRP levels were 102 +/- 31 mm/h and 51 +/- 20 mg/l, respectively. In multivariable analysis, high CRP levels were independently predictive of mortality, major complications, embolic events and need for urgent surgery. A CRP >40 mg/l predicted adverse outcomes with a sensitivity of 73% and specificity of 99%. Conclusion: The study shows that baseline CRP level in the first 3 days of admission is a strong predictor of short term adverse outcomes in IE patients, and a useful marker for early risk stratification. (C) 2018 Published by Elsevier B.V. on behalf of Cardiological Society of India.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available